62
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Lower serum brain-derived neurotrophic factor levels are associated with failure to achieve remission in patients with major depression after escitalopram treatment

, , &
Pages 1393-1398 | Published online: 23 Jul 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kuan-Wei Huang & Tiao-Lai Huang. (2023) Association between programmed death-1 pathway and major depression. The World Journal of Biological Psychiatry 24:9, pages 822-828.
Read now

Articles from other publishers (3)

Sagun Tiwari, Lili Qi, John Wong & Zhenxiang Han. (2022) Association of peripheral manifestation of brain‐derived neurotrophic factor with depression: A meta‐analysis. Brain and Behavior 12:6.
Crossref
Vlad Dionisie, Adela Magdalena Ciobanu, Vlad Alexandru Toma, Mihnea Costin Manea, Ioana Baldea, Diana Olteanu, Alexandra Sevastre-Berghian, Simona Clichici, Mirela Manea, Sorin Riga & Gabriela Adriana Filip. (2021) Escitalopram Targets Oxidative Stress, Caspase-3, BDNF and MeCP2 in the Hippocampus and Frontal Cortex of a Rat Model of Depression Induced by Chronic Unpredictable Mild Stress. International Journal of Molecular Sciences 22:14, pages 7483.
Crossref
Alexandra S. Troyan & Oleg A. Levada. (2020) The Diagnostic Value of the Combination of Serum Brain-Derived Neurotrophic Factor and Insulin-Like Growth Factor-1 for Major Depressive Disorder Diagnosis and Treatment Efficacy. Frontiers in Psychiatry 11.
Crossref